Development and Characterization of Bioinspired Cationic Lipid Nanocarriers for Enhanced Anti-Cancer Vaccine Delivery and Tumor Inhibition: In Vitro and In Vivo Evaluation
Clicks: 2
ID: 298885
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
0.3
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #15 of 18 articles by views in Current Pharmaceutical Letters And Reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This study develops and characterizes bioinspired nanocarriers for anti-cancer vaccination delivery and efficacy. Cationic lipid nanoparticles (CLP) were combined with cancer cell membrane fractions to generate a new Cancer Membrane Delivery System. DLS and TEM were used to analyse the nanoparticles' size distribution, zeta potential, and morphology. To ensure safety and efficacy, biocompatibility, cytotoxicity, and nucleic acid encapsulation efficiency were tested. In vitro and in vivo studies showed nanoparticles' high cellular absorption and tumor growth inhibition. Immunological and blood parameter analyses suggested immunomodulation. Statistical study using ANOVA showed substantial immunological and blood parameter differences between nanoparticle formulations. This work shows that bioinspired nanocarriers may be promising cancer treatment platforms.
| Reference Key |
imported_1761755819_690242ab52a9c
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Suraj Mandal |
| Journal | Current Pharmaceutical Letters And Reviews |
| Year | 2024 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.